233 related articles for article (PubMed ID: 12161188)
1. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system.
Kaneda Y; Nakajima T; Nishikawa T; Yamamoto S; Ikegami H; Suzuki N; Nakamura H; Morishita R; Kotani H
Mol Ther; 2002 Aug; 6(2):219-26. PubMed ID: 12161188
[TBL] [Abstract][Full Text] [Related]
2. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
[TBL] [Abstract][Full Text] [Related]
3. Development of HVJ envelope vector and its application to gene therapy.
Kaneda Y; Yamamoto S; Nakajima T
Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
[TBL] [Abstract][Full Text] [Related]
4. HVJ liposomes and HVJ envelope vectors.
Kaneda Y
Cold Spring Harb Protoc; 2011 Oct; 2011(10):1281-9. PubMed ID: 21969614
[TBL] [Abstract][Full Text] [Related]
5. Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin.
Kawachi M; Tamai K; Saga K; Yamazaki T; Fujita H; Shimbo T; Kikuchi Y; Nimura K; Nishifuji K; Amagai M; Uitto J; Kaneda Y
Hum Gene Ther; 2007 Oct; 18(10):881-94. PubMed ID: 17892442
[TBL] [Abstract][Full Text] [Related]
6. Kupffer cell targeting by intraportal injection of the HVJ cationic liposome.
Yoshida M; Yamamoto N; Uehara T; Terao R; Nitta T; Harada N; Hatano E; Iimuro Y; Yamaoka Y
Eur Surg Res; 2002; 34(3):251-9. PubMed ID: 12077513
[TBL] [Abstract][Full Text] [Related]
7. Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector.
Mima H; Tomoshige R; Kanamori T; Tabata Y; Yamamoto S; Ito S; Tamai K; Kaneda Y
J Gene Med; 2005 Jul; 7(7):888-97. PubMed ID: 15712245
[TBL] [Abstract][Full Text] [Related]
8. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector.
Morishita N; Nakagami H; Morishita R; Takeda S; Mishima F; Terazono B; Nishijima S; Kaneda Y; Tanaka N
Biochem Biophys Res Commun; 2005 Sep; 334(4):1121-6. PubMed ID: 16134237
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient and minimally invasive in-vivo gene transfer to the mouse uterus using haemagglutinating virus of Japan (HVJ) envelope vector.
Nakamura H; Kimura T; Ikegami H; Ogita K; Koyama S; Shimoya K; Tsujie T; Koyama M; Kaneda Y; Murata Y
Mol Hum Reprod; 2003 Oct; 9(10):603-9. PubMed ID: 12970398
[TBL] [Abstract][Full Text] [Related]
10. New vector innovation for drug delivery: development of fusigenic non-viral particles.
Kaneda Y
Curr Drug Targets; 2003 Nov; 4(8):599-602. PubMed ID: 14577648
[TBL] [Abstract][Full Text] [Related]
11. Development of HVJ Envelope Vector and Its Application to Gene Therapy.
Kaneda Y; Yamamoto S; Nakajima T
Adv Genet; 2005; 53PA():307-332. PubMed ID: 16243069
[TBL] [Abstract][Full Text] [Related]
12. Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope.
Matsuda M; Yamamoto T; Matsumura A; Kaneda Y
Gene Ther; 2009 Dec; 16(12):1465-76. PubMed ID: 19675593
[TBL] [Abstract][Full Text] [Related]
13. The HVJ-envelope as an innovative vector system for cardiovascular disease.
Kotani H; Nakajima T; Lai S; Morishita R; Kaneda Y
Curr Gene Ther; 2004 Jun; 4(2):183-94. PubMed ID: 15180584
[TBL] [Abstract][Full Text] [Related]
14. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
Kaneda Y
Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
[TBL] [Abstract][Full Text] [Related]
15. Electroporation-mediated gene transfer that targets glomeruli.
Tsujie M; Isaka Y; Nakamura H; Imai E; Hori M
J Am Soc Nephrol; 2001 May; 12(5):949-954. PubMed ID: 11316853
[TBL] [Abstract][Full Text] [Related]
16. Development of a transferrin receptor-targeting HVJ-E vector.
Shimbo T; Kawachi M; Saga K; Fujita H; Yamazaki T; Tamai K; Kaneda Y
Biochem Biophys Res Commun; 2007 Dec; 364(3):423-8. PubMed ID: 17961511
[TBL] [Abstract][Full Text] [Related]
17. Total vascular exclusion safely facilitates liver specific gene transfer by the HVJ (sendai virus)-liposome method in rats.
Kawashita Y; Fujioka H; Ohtsuru A; Kuroda H; Eguchi S; Kaneda Y; Yamashita S; Kanematsu T
J Surg Res; 2006 May; 132(1):136-41. PubMed ID: 16337969
[TBL] [Abstract][Full Text] [Related]
18. Functional modification of Sendai virus by siRNA.
Saga K; Tamai K; Kawachi M; Shimbo T; Fujita H; Yamazaki T; Kaneda Y
J Biotechnol; 2008 Feb; 133(3):386-94. PubMed ID: 18093677
[TBL] [Abstract][Full Text] [Related]
19. Development of liposomes and pseudovirions with fusion activity for efficient gene delivery.
Kaneda Y
Curr Gene Ther; 2011 Dec; 11(6):434-41. PubMed ID: 22023472
[TBL] [Abstract][Full Text] [Related]
20. HVJ-envelope vector for gene transfer into central nervous system.
Shimamura M; Morishita R; Endoh M; Oshima K; Aoki M; Waguri S; Uchiyama Y; Kaneda Y
Biochem Biophys Res Commun; 2003 Jan; 300(2):464-71. PubMed ID: 12504107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
